Targeting HE4 for treatment of endometrial cancer using a novel small molecule inhibitor. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full ...
As artificial intelligence technology continues to improve, more companies have become interested in machine learning—technology that is able to “learn” and adapt to become increasingly adept at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback